Newly-Published Study Compares SURFAXIN® with Animal-Derived Surfactants in Well-Established Model of RDS
04:51 EDT 6 Sep 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
WARRINGTON, Pa., Sept. 6, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the publication of SURFAXIN® (lucina...
Other Sources for this Article
More From BioPortfolio on "Newly-Published Study Compares SURFAXIN® with Animal-Derived Surfactants in Well-Established Model of RDS"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
